In the past, the pharmaceutical industry has relied on extensive, expensive clinical testing for new drugs, including animal testing and increased failures in human testing. With the FDA and global regulators rethinking clinical trial standards to minimize animal testing, and the fact that animals aren’t the best predictors for human success, there needs to be another solution.
Quris-AI is completely disrupting the pharma industry by utilizing its Bio-AI platform that uniquely combines cutting-edge artificial intelligence together with patients-on-chip technology. By combining their expertise in science and biology with AI, Quris can now more accurately predict the safety of drugs in humans.
